Stix

What Stix does

Stix is a female-founded, Philadelphia-based consumer health company founded in 2018 that develops women's health products supported by educational content and community resources aimed at women making informed health decisions. The company markets itself as a "no-judgment health brand," combining product offerings with content and community rather than focusing on a single SKU; however, specific product details have remained undisclosed across public sources, with the most recent (April 2022) funding round earmarked for development of a new women's health product. Co-founded by Cynthia Plotch and Jamie Norwood, Stix has positioned itself in the direct-to-consumer women's health vertical with a brand identity centered on female founders and accessibility.

The company operates as a private, for-profit venture-backed startup with 11-50 employees. Its business model and pricing are not publicly disclosed; the company website (getstix.co) currently redirects to Siemens Healthineers content returning 404 errors, indicating the original brand web presence is no longer active under the Stix name. No distribution channels, marketing channels, customer logos, or revenue figures are disclosed in available sources.

Stix has raised approximately $6.38 million cumulatively across four funding rounds between June 2019 and April 2022. Investors include Resolute Ventures and SWAT Equity Partners (co-leading the two most recent rounds), as well as (ERA) Entrepreneurs Roundtable Accelerator, 1745 Ventures, Fab Co-Creation Studio Ventures, Founders Factory, Overeasy Ventures, Rogue Women's Fund, VamosVentures, Bullish, Chaos Ventures, and Umami Capital — a notable concentration of women-focused and consumer-oriented funds. No acquisitions, partnerships, patents, regulatory actions, leadership changes, or subsequent funding rounds are disclosed in the input data after April 2022.

Name

Stix

Website

https://getstix.co

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Women's Health Products

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK)

akta.pro secondary industries

Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN), Menstrual Pain Relief & Period Care Supplements (CRABAIAJ)

Keywords

• Women's health products
• Feminine care products
• Consumer health brand
• Personal wellness products
• Women's wellness brand

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Supply Chain

Core offering

Stix is a female-founded, no-judgment women's health brand based in Philadelphia that combines products, content, and community to help women make informed health decisions. The company was developing a new women's health product funded by a $1.48 million capital raise in April 2022, with specific product details remaining undisclosed at the time of the announcement.

Product overview

Stix is a women's health company that raised $1.48 million in April 2022 to develop a new women's health product. Specific product details are currently undisclosed. The company website (getstix.co) redirects to Siemens Healthineers content, suggesting a potential acquisition or domain redirect.

Differentiator

Problem solved

Functional benefit

Products and services

• Women's Health Products Stix's line of no-judgment women's health products, targeted at individual women seeking trusted, destigmatized health solutions. Specific product SKUs and details were undisclosed as of April 2022, when the company raised $1.48 million to develop a new women's health product offering.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Hims & Hers Health: Hims & Hers is a scaled consumer telehealth and health products platform selling OTC and prescription treatments directly to consumers. It competes with Stix for the same women's health DTC wallet and offers a much broader portfolio, making it a broad incumbent in the adjacent consumer health space Stix targets.

Direct peers

• Wisp: Wisp is a women's health brand offering telehealth consultations and at-home treatments for UTIs, yeast infections, herpes, and other conditions — closely mirroring Stix's original women's health product mix and direct-to-consumer model.
• Tia: Tia operates a women's health clinic and care platform delivering integrated gynecological, primary, and mental health services. It is comparable to Stix as a female-founded women's health brand pursuing both physical product and clinical care approaches.
• Maven Clinic: Maven Clinic is a virtual women's and family health platform covering fertility, maternity, and postpartum care. It competes with Stix in women's health and has overlapping target customers and a similar digital-first delivery model.
• Kindbody: Kindbody is a fertility and women's health company offering virtual care and clinic-based services. It overlaps Stix in reproductive and women's health consumer segments and follows a similar hybrid digital/physical model.
• Ritual: Ritual is a women's-focused vitamins and supplements brand selling DTC through subscription. It is directly comparable to Stix's CPG/supplements angle, particularly for prenatal and women's health formulations.
• The Honey Pot Company: The Honey Pot Company is a female-founded feminine care brand offering washes, wipes, and menstrual products through DTC and retail channels. It is comparable to Stix as a women's personal care/wellness CPG brand targeting similar end consumers.
• LOLA: LOLA is a women's health CPG brand best known for organic tampons and feminine care products, selling DTC and through retail. It shares Stix's positioning as a no-judgment, women-led consumer brand in feminine wellness.
• Nurx: Nurx is a telehealth platform providing prescription and at-home testing services for reproductive and sexual health. It overlaps directly with Stix's historical STI, contraception, and at-home testing offerings and target customers.
• Ro (Rory): Ro operates consumer health brands including Rory, a women's health vertical focused on perimenopause and menopause. It competes with Stix for women's health consumer share and benefits from Ro's broader telehealth infrastructure.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/getstix

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds4 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stix